Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies

NCT01178346 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Smoking Cessation

Interventions

BIOLOGICAL: NicVAX vaccine
BIOLOGICAL: Placebo

Sponsor

Nabi Biopharmaceuticals

Collaborators

[object Object]